Key result
A high-sensitivity cardiac troponin I threshold of <2 ng/L at presentation ruled out acute myocardial infarction with a sensitivity of 99.0% and NPV of 99.8%.
Why the study?
Does a single baseline high-sensitivity cardiac troponin I measurement safely rule out acute myocardial infarction in patients presenting with symptoms of acute coronary syndrome?
Observational (n=1,871)
No
Does a single baseline high-sensitivity cardiac troponin I measurement safely rule out acute myocardial infarction in patients presenting with symptoms of acute coronary syndrome?
A single baseline hs-cTnI <2 ng/L using the Beckman Coulter Access assay safely rules out acute myocardial infarction with 99% sensitivity and 99.8% NPV.
Answers are grounded in this paper and cite their sources.
May support single hs-cTnI testing for early T1MI rule-out in ED; leaves open prospective validation before practice change.
BACKGROUND: Low concentrations of cardiac troponin (cTn) have been recommended for rapid rule-out of acute myocardial infarction (AMI). We examined the Beckman Coulter Access high-sensitivity cardiac troponin I (hs-cTnI) assay to identify a single test threshold that can safely rule out AMI. METHODS: This analysis used stored samples collected in 2 prospective observational studies. In all, 1871 patients presenting to a tertiary emergency department with symptoms of acute coronary syndrome had blood taken for measurement of cTnI on presentation. The endpoint was type 1 myocardial infarction (T1MI). Sensitivity and negative predictive value (NPV) were calculated for hs-cTnI values below the 99th percentile. RESULTS: Ninety-eight patients had T1MI (5.2%), and 638 (34.1%) patients had an hs-cTnI <2 ng/L (limit of detection), with sensitivity of 99.0% (95% CI, 94.4%-100%) and NPV of 99.8% (95% CI, 99.1%-100%). No hs-cTnI value above a concentration of 2 ng/L achieved sensitivity of 99%. However, an NPV of 99.5% was achieved at values <6 ng/L. A cutoff <6 ng/L enabled 1475 (78.8%) patients to be ruled out on presentation with sensitivity of 93.9% (95% CI, 87.1%-97.7%). CONCLUSIONS: A single baseline cTn <2 ng/L measured with the Access hs-cTnI assay performed well for rule-out of AMI. This cutoff concentration identified 99% of patients with AMI and could reduce the number of patients requiring lengthy assessment. A cutoff of <6 ng/L yielded a high NPV but missed more cases of AMI than would be acceptable to clinicians.
No takes yet. Share an insight, caveat, or question.
Greenslade et al. (2018) conducted an observational in acute coronary syndrome (n=1,871). High-sensitivity cardiac troponin I (hs-cTnI) assay <2 ng/L threshold was evaluated on type 1 myocardial infarction (T1MI) (Sensitivity 99.0%, 95% CI 94.4%-100%). A high-sensitivity cardiac troponin I threshold of <2 ng/L at presentation ruled out acute myocardial infarction with a sensitivity of 99.0% and NPV of 99.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: